Open an account

Medline

MDLN · NASDAQ

$35.46+$0.27 (+0.77%)TodayMarket closed ·
Prev close $35.19

About MDLN

Medline, Inc. engages in the provision of medical-surgical products and supply chain solutions. The company is headquartered in Northfield, Illinois and currently employs 45,000 full-time employees. The company went IPO on 2025-12-17. The firm delivers mission-critical products used daily across the full range of care settings, from hospitals and surgery centers to physician offices and post-acute facilities. The company operates through two segments: Medline Brand and Supply Chain Solutions. These segments offer approximately 335,000 medical-surgical products, including surgical and procedural kits, gloves and protective apparel, urological and incontinence care, wound care, and consumable lab and diagnostics products. Its Medline Brand products are organized into three product categories: Front Line Care, Surgical Solutions, and Laboratory and Diagnostics. The Supply Chain Solutions segment procures and distributes a variety of third-party products from national brands and also provides tailored logistics and supply chain optimization services to domestic and international consumers.

Employees
45,000
Headquarters
Northfield, Illinois
Listed
Dec 17, 2025
Sector
Health Care
Industry
Health Care Equipment & Supplies
Website
ir.medline.com

MDLN key statistics

Market cap
46.26B
Price-earnings ratio
0.00
Dividend yield
—
Average volume
8.30M
Volume
9.60M
Open price
$35.47
High today
$36.12
Low today
$35.25
52 Week high
$50.88
52 Week low
$31.49

Medline (MDLN) at a glance

Medline (MDLN) last traded at $35.46, with a market cap of 46.26B and a price-to-earnings ratio of 0.00.

Today the stock has traded between $35.25 and $36.12. The current price is 0.6% above the day's low and 1.8% below its high.

Volume so far is 9.60M shares, in line with the average of 8.30M shares a day.

Over the past year Medline has ranged from $31.49 to $50.88, and now sits 20% of the way up that range.

Medline met or beat analyst EPS estimates in 3 of the last 3 quarters. In Q2 FY26 it reported $0.50 per share against an estimate of $0.3285.

The average analyst price target is $45.33, 27.8% above the current price, from 24 recent ratings.

Analyst ratings

Latest rating from each analyst over the past 12 months

83%of 24 analyst ratings say Buy
  • Buy83.3%
  • Hold16.7%
  • Sell0.0%
Price target · 29 analystsAvg $45.33
Low
$34.34
Now
$35.46
High
$57.75

MDLN earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 3 of the last 3 quarters, by 43.6% on average.

  1. Q4 FY25: reported $0.43 per share against an estimate of $0.2541
  2. Q1 FY26: reported $0.33 per share against an estimate of $0.3014
  3. Q2 FY26: reported $0.50 per share against an estimate of $0.3285

MDLN news

  • Press releasePRNewswire

    Medline to build Midwestern network with new 800,000-square-foot facility in Van Buren Township, Mich.

  • Press releasePRNewswire

    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Medline Inc. - MDLN

  • Press releaseNewsfile

    Medline Inc. Investigation Continues: Investors May Contact Kirby McInerney LLP, a Securities Fraud Law Firm, If You Lost Money On Your MDLN Investments

  • Press releaseGlobe Newswire

    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Medline Inc. - MDLN

  • Press releasePRNewswire

    MDLN Stock Alert: Medline Product Quality Issues and Subsequent 13% Stock Drop Trigger Securities Fraud Investigation for Investors

  • Press releasePRNewswire

    Medline launches enhanced TrackPoint™ to simplify inventory management for post-acute care

  • Press releaseGlobe Newswire

    MDLN Investigation News: The Medline Securities Fraud Investigation into 13% Stock Drop is Pending – Investors Notified to Contact BFA Law

  • Press releaseNewsfile

    MDLN ALERT: Kaplan Fox & Kilsheimer LLP is Investigating Medline Inc. (MDLN) for Potential Securities Law Violations

Similar companies

Companies in the same industry as Medline

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.